» Articles » PMID: 34606886

Autoantibodies Present in Hidradenitis Suppurativa Correlate with Disease Severity and Promote the Release of Proinflammatory Cytokines in Macrophages

Abstract

Hidradenitis suppurativa (HS), also known as acne inversa, is a debilitating inflammatory skin disorder that is characterized by nodules that lead to the development of connected tunnels and scars as it progresses from Hurley stages I to III. HS has been associated with several autoimmune diseases, including inflammatory bowel disease and spondyloarthritis. We previously reported dysregulation of humoral immune responses in HS, characterized by elevated serum total IgG, B-cell activation, and antibodies recognizing citrullinated proteins. In this study, we characterized IgG autoreactivity in HS sera and lesional skin compared with those in normal healthy controls using an array-based high-throughput autoantibody screening. The Cy3-labeled anti-human assay showed the presence of autoantibodies against nuclear antigens, cytokines, cytoplasmic proteins, extracellular matrix proteins, neutrophil proteins, and citrullinated antigens. Most of these autoantibodies were significantly elevated in stages II‒III in HS sera and stage III in HS skin lesions compared with those of healthy controls. Furthermore, immune complexes containing both native and citrullinated versions of antigens can activate M1 and M2 macrophages to release proinflammatory cytokines such as TNF-α, IL-8, IL-6, and IL-12. Taken together, the identification of specific IgG autoantibodies that recognize circulating and tissue antigens in HS suggests an autoimmune mechanism and uncovers putative therapeutic targets.

Citing Articles

B cells in non-lymphoid tissues.

Samiea A, Celis G, Yadav R, Rodda L, Moreau J Nat Rev Immunol. 2025; .

PMID: 39910240 DOI: 10.1038/s41577-025-01137-6.


Hidradenitis suppurativa: TLSs take the center stage.

Elkins C, Li C Immunity. 2024; 57(12):2712-2714.

PMID: 39662086 PMC: 11790253. DOI: 10.1016/j.immuni.2024.11.011.


CD2 expressing innate lymphoid and T cells are critical effectors of immunopathogenesis in hidradenitis suppurativa.

Kashyap M, Mishra B, Sinha R, Jin L, Gou Y, Kumar N Proc Natl Acad Sci U S A. 2024; 121(48):e2409274121.

PMID: 39560648 PMC: 11621750. DOI: 10.1073/pnas.2409274121.


Hidradenitis suppurativa: key insights into treatment success and failure.

van Straalen K, Piguet V, Gudjonsson J J Clin Invest. 2024; 134(21).

PMID: 39484718 PMC: 11527436. DOI: 10.1172/JCI186744.


IgG4 serologic elevation in a patient with severe hidradenitis suppurativa: a case report and review of the literature.

Gauger A, Fritz M, Burgin C Front Med (Lausanne). 2024; 11:1471226.

PMID: 39464270 PMC: 11502415. DOI: 10.3389/fmed.2024.1471226.


References
1.
Abbate A, Van Tassell B, Biondi-Zoccai G . Blocking interleukin-1 as a novel therapeutic strategy for secondary prevention of cardiovascular events. BioDrugs. 2012; 26(4):217-33. DOI: 10.1007/BF03261881. View

2.
Miyakis S, Lockshin M, Atsumi T, Branch D, Brey R, Cervera R . International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006; 4(2):295-306. DOI: 10.1111/j.1538-7836.2006.01753.x. View

3.
Vlassova N, Kuhn D, A Okoye G . Hidradenitis suppurativa disproportionately affects African Americans: a single-center retrospective analysis. Acta Derm Venereol. 2015; 95(8):990-1. DOI: 10.2340/00015555-2176. View

4.
Carmona-Rivera C, Kaplan M . Detection of SLE antigens in neutrophil extracellular traps (NETs). Methods Mol Biol. 2014; 1134:151-61. PMC: 4123114. DOI: 10.1007/978-1-4939-0326-9_11. View

5.
Zuurbier C, Abbate A, Cabrera-Fuentes H, Cohen M, Collino M, de Kleijn D . Innate immunity as a target for acute cardioprotection. Cardiovasc Res. 2018; 115(7):1131-1142. PMC: 6529915. DOI: 10.1093/cvr/cvy304. View